Invesco Ltd. Acadia Pharmaceuticals Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 558,064 shares of ACAD stock, worth $9.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

558,064

Previous 85,424 553.29%

Holding current value

$9.14 Million

Previous $1.39 Million 518.73%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $7.16 Million - $9.05 Million	472,640 Added 553.29%	558,064 $8.59 Million
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $3.87 Million - $4.88 Million	-264,963 Reduced 75.62%	85,424 $1.39 Million
Q1 2024 May 14, 2024	SELL	$17.79 - $30.86 $1.29 Million - $2.24 Million	-72,582 Reduced 17.16%	350,387 $6.48 Million
Q4 2023 Feb 12, 2024	BUY	$20.78 - $31.77 $1.87 Million - $2.86 Million	89,997 Added 27.03%	422,969 $13.2 Million
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $1.35 Million - $2.16 Million	-64,548 Reduced 16.24%	332,972 $6.94 Million
Q2 2023 Aug 11, 2023	SELL	$17.8 - $25.65 $1.36 Million - $1.96 Million	-76,450 Reduced 16.13%	397,520 $9.52 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $1.01 Million - $1.29 Million	-61,774 Reduced 11.53%	473,970 $8.92 Million
Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $778,500 - $1.02 Million	54,824 Added 11.4%	535,744 $8.53 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $440,598 - $570,499	31,226 Added 6.94%	480,920 $7.87 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $340,497 - $712,401	-26,172 Reduced 5.5%	449,694 $6.34 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $8.57 Million - $11.3 Million	409,120 Added 612.95%	475,866 $11.5 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $80,524 - $129,923	-4,796 Reduced 6.7%	66,746 $1.56 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $136,118 - $213,666	8,626 Added 13.71%	71,542 $1.19 Million
Q2 2021 Aug 17, 2021	SELL	$19.4 - $27.42 $87,785 - $124,075	-4,525 Reduced 6.71%	62,916 $1.54 Million
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $28.2 Million - $61.9 Million	-1,125,174 Reduced 94.35%	67,441 $1.74 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $36.6 Million - $50.6 Million	891,392 Added 295.92%	1,192,615 $63.8 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $140,981 - $220,647	-3,871 Reduced 1.27%	301,223 $12.4 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $10.5 Million - $14.2 Million	-268,532 Reduced 46.81%	305,094 $14.8 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $30.1 Million - $44.6 Million	-950,634 Reduced 62.37%	573,626 $24.2 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $93.7 Million - $133 Million	-2,587,265 Reduced 62.93%	1,524,260 $65.2 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $2.13 Million - $4.23 Million	96,043 Added 2.39%	4,111,525 $148 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $84.7 Million - $102 Million	3,633,171 Added 950.32%	4,015,482 $107 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $2.09 Million - $3.55 Million	-129,476 Reduced 25.3%	382,311 $10.3 Million
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $7.33 Million - $11.7 Million	511,787 New	511,787 $8.28 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account